EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificate
I'm PortAI, I can summarize articles.
EASTON BIOPHARMACEUTICALS' wholly-owned subsidiary Chengdu ShuoDe Pharmaceutical recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration, with the drug name being Etifoxine Hydrochloride Tablets. This medication is primarily used to improve muscle tension states in conditions such as cervical shoulder-arm syndrome, shoulder periarthritis, and low back pain, as well as spastic paralysis caused by various brain and spinal cord diseases
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments